Systematic characterization of therapeutic vulnerabilities in Multiple Myeloma with Amp1q reveals increased sensitivity to the combination of MCL1 and PI3K inhibitors
R. Sklavenitis-Pistofidis, E. D. Lightbody, M. Reidy, J. Tsuji, M. P. Aranha, D. Heilpern-Mallory, D. Huynh, S. J. F. Chong, L. Hackett, N. J. Haradhvala, T. Wu, N. K. Su, B. Berrios, J.-B. Alberge, A. Dutta, , S. Manier
bioRxiv · Aug 1, 2023 · PreprintCancer Biology